You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TRELEGY ELLIPTA

Showing 1 - 25 of 61
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Disease, Chronic Obstructive Trial (FF/UMEC/VI)

Not yet recruiting
  • Pulmonary Disease, Chronic Obstructive
  • (no location specified)
Sep 7, 2022

Copd Trial in Dallas (TRELEGY ELLIPTA 100Mcg-62.5Mcg-25Mcg/Actuation Powder for Inhalation)

Not yet recruiting
  • Copd
  • TRELEGY ELLIPTA 100Mcg-62.5Mcg-25Mcg/Actuation Powder for Inhalation
  • Dallas, Texas
    Baylor Scott & White Health Research Institute
Mar 22, 2022

US Based on Pharmacy and Medical Claims That Compares How Well

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Trelegy Ellipta
  • +3 more
  • White Plains, New York
    eMax health
Jan 11, 2022

COPD Trial in Farmington Hills (Trelegy Ellipta 100/62.5/25Mcg Inh 30D, Ventolin 90Mcg/Actuation Inhalation Aerosol)

Completed
  • COPD
  • Trelegy Ellipta 100/62.5/25Mcg Inh 30D
  • Ventolin 90Mcg/Actuation Inhalation Aerosol
  • Farmington Hills, Michigan
    Pulmonary Research Institute of Southeast Michigan
Dec 15, 2021

Using US Medical and Pharmacy Claim Records to Compare Resource

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Trelegy Ellipta
  • +3 more
  • Eden Prairie, Minnesota
    Optum
Mar 11, 2022

Pulmonary Disease, Chronic Obstructive Trial in Waterbury, Charlotte, Layton (Inhaled corticosteroids/long-acting

Withdrawn
  • Pulmonary Disease, Chronic Obstructive
  • Inhaled corticosteroids/long-acting beta2-adrenergic/long-acting muscarinic receptor antagonists
  • Fluticasone furoate/umeclidinium/vilanterol
  • Waterbury, Connecticut
  • +2 more
Apr 21, 2020

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (FF/UMEC/VI, Inhaled Corticosteroid, LAMA)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Aschaffenburg, Bayern, Germany
  • +142 more
Aug 19, 2020

Asthma Trial (FF/UMEC/VI, ELLIPTA, FF/VI)

Not yet recruiting
  • Asthma
  • (no location specified)
Feb 24, 2023

Asthma Trial in China (FF/VI, FF/UMEC/VI, ELLIPTA)

Recruiting
  • Asthma
  • Xiamen, Fujian, China
  • +40 more
Oct 25, 2022

Pulmonary Disease, Chronic Obstructive Trial (FF/UMEC/VI, ELLIPTA)

Not yet recruiting
  • Pulmonary Disease, Chronic Obstructive
  • (no location specified)
Aug 15, 2022

Asthma Trial (FF/UMEC/VI)

Not yet recruiting
  • Asthma
  • (no location specified)
Nov 25, 2020

COPD Trial (Beclometasone Dipropionate / Formoterol Fumarate / Glycopyrronium 100/6/10 mcg, Fluticasone Furoate / Vilanterol

Withdrawn
  • COPD
  • Beclometasone Dipropionate / Formoterol Fumarate / Glycopyrronium 100/6/10 mcg
  • Fluticasone Furoate / Vilanterol Trifenatate 100/25 mcg
  • (no location specified)
Jan 19, 2022

Asthma Trial in Enschede, Nijverdal, Rotterdam (ELLIPTA, BREEZHALER)

Completed
  • Asthma
  • ELLIPTA
  • BREEZHALER
  • Enschede, Netherlands
  • +2 more
Oct 7, 2021

Asthma Trial in Worldwide (FF/VI via ELLIPTA DPI, FF via ELLIPTA DPI)

Completed
Has Results
  • Asthma
  • FF/VI via ELLIPTA DPI
  • FF via ELLIPTA DPI
  • Hoover, Alabama
  • +183 more
Sep 12, 2022

Asthma Trial in Canada, United States (drug, device, other)

Completed
Has Results
  • Asthma
  • Placebo DPI
  • +2 more
  • Little Rock, Arkansas
  • +18 more
Feb 26, 2021

Asthma Trial in Worldwide (RELVAR/BREO, Salbutamol, Smart phone app)

Completed
Has Results
  • Asthma
  • Aventura, Florida
  • +65 more
Mar 17, 2021

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (Placebo ELLIPTA, Nemiralisib ELLIPTA 50 µg, Nemiralisib ELLIPTA 100

Terminated
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Placebo ELLIPTA
  • +7 more
  • Mobile, Alabama
  • +161 more
Jul 13, 2021

Arnuity® Ellipta® Drug Use Investigation

Completed
  • Asthma
  • Arnuity Ellipta
  • Hokkaido, Japan
  • +1 more
Apr 22, 2021

RELVAR® 100 ELLIPTA® Special Drug Use Investigation

Completed
  • Pulmonary Disease, Chronic Obstructive
  • RELVAR 100 ELLIPTA
  • Hokkaido, Japan
  • +1 more
Jul 26, 2021

Error Rates Between ELLIPTA® Dry Powder Inhaler and Other DPIs

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Relvar ELLIPTA
  • +6 more
  • Beek En Donk, Netherlands
  • +12 more
Oct 6, 2020

Pulmonary Disease, Chronic Obstructive Trial in Poland, Russian Federation, United States (FF/UMEC/VI, Tiotropium,

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Andalusia, Alabama
  • +71 more
Jul 13, 2021

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (budesonide/formoterol, albuterol/salbutamol, FF/UMEC/VI)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Gold River, California
  • +56 more
Oct 7, 2020

Pulmonary Disease, Chronic Obstructive Trial in Czechia, Germany, United States (budesonide/formoterol, albuterol/salbutamol,

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Mobile, Alabama
  • +56 more
Oct 7, 2020

Asthma Trial in Worldwide (FF/UMEC/VI (100/31.25/25) mcg, FF/UMEC/VI (100/62.5/25) mcg, FF/UMEC/VI (200/31.25/25) mcg)

Completed
Has Results
  • Asthma
  • FF/UMEC/VI (100/31.25/25) mcg
  • +10 more
  • Birmingham, Alabama
  • +408 more
Feb 26, 2021

Pulmonary Disease, Chronic Obstructive Trial in Canada, Denmark (GSK2269557, Placebo, DISKUS)

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Vancouver, British Columbia, Canada
  • +5 more
Aug 12, 2021